Electronic death registration is a win-win for SA – let’s make it happen

Electronic death registration is a win-win for SA – let’s make it happen

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • Electronic death registration is a win-win for SA – let’s make it happen

    Several studies have flagged problems with South Africa’s death registration processes. A critical first step to addressing it is to replace our paper-based process with an electronic one, argue Dr Pam Groenewald and Professor Debbie Bradshaw, both of the SAMRC’s Burden of Disease Research Unit.

    ·

  • Why most people in South Africa can’t get the shingles vaccine

    The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used in some other countries, but has not yet been registered in South Africa, though it can be obtained by those with money who are willing to jump through some hoops. Catherine Tomlinson reports.

    ·

  • Are children living with HIV being left behind? What the stats tell us

    Massive gains have been made in reducing new HIV infections and deaths in children. Yet, many of the statistics for children still look worse than those for adults. Elri Voigt asked experts why this is the case and what factors prevent children living with HIV from starting and staying on the treatment that can keep…

    ·

  • OPEN LETTER | Minister of Health Aaron Motsoaledi, please explain the HIV numbers

    Minister of Health Dr Aaron Motsoaledi’s recent claim that over half a million people have been newly started on HIV treatment in less than six months has raised eyebrows in health circles. In this open letter, Anna Grimsrud and Sibongile Tshabalala-Madhlala, associated with CHANGE – South Africa, ask the Minister to explain numbers that, on…

    ·

  • Why some babies in South Africa are still getting HIV

    Over the last two decades, South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7 000 babies still contract the virus every year. Experts put this down to having the right puzzle pieces for prevention but failing to integrate them optimally. Elna Schütz reports.

    ·

  • Are clinical trial participants in South Africa protected?

    Clinical trial participants appear to be well protected in South Africa, particularly as the country’s guidelines recognise the risks of research with international collaborators. The sudden end of US-funded clinical trials, however, is exposing some limitations of ethics codes and guidelines, argues Dr Andy Gray.

    ·

  • US pulls funding for South African medical research

    US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa.…

    ·

  • Large numbers of TB survivors in SA struggling with lung damage, experts say

    There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more about this under-recognised problem, Spotlight recently attended a global gathering of experts focused on life after TB.

    ·